Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease: A prospective study

被引:78
作者
Boland, LL
Folsom, AR
Rosamond, WD
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
[2] Collaborat Studies Coordinat Ctr, Chapel Hill, NC USA
关键词
African American; gallbladder; insulin; obesity; prospective;
D O I
10.1016/S1047-2797(01)00260-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE: Prospective studies of gallbladder disease have investigated a limited number of risk factors and have been conducted predominantly in women. Determinants of hospitalized gallbladder disease were examined in a large, population-based cohort of men and women. METHODS: Subjects, aged 45-64 years, were participants in the Atherosclerosis Risk in Communities (ARIC) Study who reported no history of gallbladder disease at baseline (n = 12,773). Incident cases of gallbladder disease were identified through surveillance of hospital discharges between the baseline visit (1987-1989) and 1996. RESULTS: The crude incidence rate of hospitalized gallbladder disease was 3.8 per 1000 person-years. In women, increasing risk was observed for increasing levels of body-mass index and waist-to-hip ratio, whereas in men, increased risk was observed only in the morbidly obese (BMI greater than or equal to 35). Fasting serum insulin, low HDL cholesterol, elevated triglycerides, and hormone replacement therapy were all positively associated with gallbladder disease risk. The relative risks associated with having one, two, or three or more components of the "multiple metabolic syndrome" in men were 1.45 (95% CI = 0.9-2.3), 2.17 (1.3-3.6), and 2.34 (1.3-4.3), respectively. CONCLUSIONS: In men, hyperinsulinemia and dyslipidemia may have some role in the etiology of gallbladder disease beyond their association with obesity, whereas in women, increased body size, central adiposity, and hormone replacement therapy may be more important determinants of gallbladder disease. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 52 条
  • [31] Epidemiology of cholelithiasis in southern Italy .2. Risk factors
    Misciagna, G
    Leoci, C
    Guerra, V
    Chiloiro, M
    Elba, S
    Petruzzi, J
    Mossa, A
    Noviello, MR
    Coviello, A
    Minutolo, MC
    Mangini, V
    Messa, C
    Cavallini, A
    DeMichele, G
    Giorgio, I
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (06) : 585 - 593
  • [32] MOERMAN CJ, 1994, INT J OBESITY, V18, P435
  • [33] CHRONOLOGY OF CHOLELITHIASIS - DATING GALLSTONES FROM ATMOSPHERIC RADIOCARBON PRODUCED BY NUCLEAR BOMB EXPLOSIONS
    MOK, HYI
    DRUFFEL, ERM
    RAMPONE, WM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (17) : 1075 - 1077
  • [34] *NAT HEART LUNG BL, 1987, 8 ARIC NAT HEART LUN
  • [35] *NAT HEART LUNG BL, 1987, 10 ARIC NAT HEART LU
  • [36] The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects
    Niemi, M
    Kervinen, K
    Rantala, A
    Kauma, H
    Päivänsalo, M
    Savolainen, MJ
    Lilja, M
    Kesäniemi, YA
    [J]. GUT, 1999, 44 (04) : 557 - 562
  • [37] PETERS KD, 1998, 479 NAT CTR HLTH STA
  • [38] OBESITY AND CHOLECYSTECTOMY AMONG WOMEN - IMPLICATIONS FOR PREVENTION
    PETITTI, DB
    SIDNEY, S
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1988, 4 (06) : 327 - 330
  • [39] ASSOCIATION OF A HISTORY OF GALLBLADDER-DISEASE WITH A REDUCED CONCENTRATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL
    PETITTI, DB
    FRIEDMAN, GD
    KLATSKY, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (23) : 1396 - 1398
  • [40] RUHL CE, 2000, HEPATHOLOGY, V31, P528